Adrianus J. de Langen

Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

Adrianus J. de Langen, Melissa L. Johnson, Julien Mazières et al. · The Lancet · 2023 · 566 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Anna-Larissa N. Niemeijer, David Leung, Marc C. Huisman et al. · Nature Communications · 2018 · 483 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Trastuzumab Deruxtecan in Patients With <i>HER2</i>-Mutant Metastatic Non–Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial

Kōichi Goto, Yasushi Goto, Toshio Kubo et al. · Journal of Clinical Oncology · 2023 · 299 citations · Full text

Medicine, Oncology, Pharmacology +17

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

Daphne van der Velden, Louisa R. Hoes, Hanneke van der Wijngaart et al. · Nature · 2019 · 269 citations · Full text

Medicine, Oncology, Pharmacology +10

Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer

Alexander Drilon, D. Ross Camidge, Sang‐We Kim et al. · New England Journal of Medicine · 2024 · 210 citations · Full text

Medicine, Oncology, Pharmacology +16